Antibodies to adult t-cell leukemia-virus-associated antigen (atla) in sera from patients with atl and controls in japan: A nation-wide sero-epidemiologic study, International Journal of Cancer, vol.79, issue.6, pp.631-635, 1982. ,
DOI : 10.1002/ijc.2910290606
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proceedings of the National Academy of Sciences, vol.77, issue.12, pp.7415-7419, 1980. ,
DOI : 10.1073/pnas.77.12.7415
New therapeutic approaches for adult T-cell leukaemia, The Lancet Oncology, vol.5, issue.11, pp.664-672, 2004. ,
DOI : 10.1016/S1470-2045(04)01608-0
URL : https://hal.archives-ouvertes.fr/hal-00098158
How I treat adult T-cell leukemia/lymphoma, Blood, vol.118, issue.7, pp.1736-1745, 2011. ,
DOI : 10.1182/blood-2011-03-345702
URL : https://hal.archives-ouvertes.fr/hal-00610253
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting, Journal of Clinical Oncology, vol.27, issue.3, pp.453-459, 2009. ,
DOI : 10.1200/JCO.2008.18.2428
URL : https://hal.archives-ouvertes.fr/hal-00356513
Adult T Cell Leukaemia, BioDrugs, vol.10, issue.6, pp.447-462, 1998. ,
DOI : 10.2165/00063030-199810060-00003
URL : https://hal.archives-ouvertes.fr/hal-00098158
Adult T-cell leukemia/lymphoma in Jamaica, pp.1986-1995 ,
Clinical Course of Retrovirus-Associated Adult T-Cell Lymphoma in the United States, New England Journal of Medicine, vol.309, issue.5, pp.257-264, 1983. ,
DOI : 10.1056/NEJM198308043090501
Adult T-cell leukemia/lymphoma., Retrovirus biology and human disease, pp.147-159, 1990. ,
DOI : 10.2169/naika.74.1210
In vivo cellular tropism of human T-cell leukemia virus type 1, J Virol, vol.64, pp.5682-5687, 1990. ,
Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated??Neuroinflammatory Disease, Viruses, vol.3, issue.12, pp.1532-1548, 2011. ,
DOI : 10.3390/v3091532
Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-1061, 2003. ,
DOI : 10.1126/science.1079490
Regulatory T cells in the past and for the future, European Journal of Immunology, vol.123, issue.4, pp.901-937, 2008. ,
DOI : 10.1002/eji.200890012
Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma, Blood, vol.61, pp.192-199, 1983. ,
Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells, Cancer Science, vol.70, issue.8, pp.527-533, 2005. ,
DOI : 10.1006/viro.1993.1451
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells, International Immunology, vol.18, issue.2, pp.269-277, 2006. ,
DOI : 10.1093/intimm/dxh366
Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells, Leukemia, vol.19, issue.3, pp.482-483, 2005. ,
DOI : 10.1038/sj.leu.2403628
Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma., British Journal of Haematology, vol.68, issue.3, pp.428-437, 1991. ,
DOI : 10.1002/ijc.2910450206
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives, Virus Research, vol.78, issue.1-2, pp.79-92, 2001. ,
DOI : 10.1016/S0168-1702(01)00286-6
Current management of adult T-cell leukemia/lymphoma, Oncology, vol.23, pp.1250-1256, 2009. ,
An Intensive Chemotherapy of Adult T-Cell Leukemia/Lymphoma: CHOP Followed by Etoposide, Vindesine, Ranimustine, and Mitoxantrone with Granulocyte Colony-Stimulating Factor Support, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.12, issue.2, pp.182-186, 1996. ,
DOI : 10.1097/00042560-199606010-00012
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303, British Journal of Haematology, vol.3, issue.2, pp.375-382, 2001. ,
DOI : 10.1038/sj.bmt.1701002
Long-term study of indolent adult T-cell leukemia-lymphoma, Blood, vol.115, issue.22, pp.4337-4343, 2010. ,
DOI : 10.1182/blood-2009-09-242347
Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes, Journal of Clinical Oncology, vol.28, issue.27, pp.4177-4183, 2010. ,
DOI : 10.1200/JCO.2010.28.0669
URL : https://hal.archives-ouvertes.fr/pasteur-00531240
Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells, Blood, vol.93, pp.278-283, 1999. ,
Arsenic-interferon-alphatriggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation, Blood, vol.96, pp.2849-2855, 2000. ,
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells, Blood, vol.101, issue.11, pp.4576-4582, 2003. ,
DOI : 10.1182/blood-2002-09-2986
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma, The Hematology Journal, vol.5, issue.2, pp.130-134, 2004. ,
DOI : 10.1038/sj.thj.6200374
URL : https://hal.archives-ouvertes.fr/hal-00102125
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia, The Journal of Experimental Medicine, vol.11, issue.13, pp.2785-2792, 2010. ,
DOI : 10.1073/pnas.94.8.3978
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL), Blood, vol.113, issue.26, pp.6528-6532, 2009. ,
DOI : 10.1182/blood-2009-03-211821
URL : https://hal.archives-ouvertes.fr/hal-00408123
Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: High interleukin-5 and -10 levels are significant unfavorable prognostic factors, International Journal of Cancer, vol.43, issue.12, pp.3054-3061, 2006. ,
DOI : 10.1002/ijc.21688
IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells, The Journal of Immunology, vol.172, issue.10, pp.5986-5993, 2004. ,
DOI : 10.4049/jimmunol.172.10.5986
Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells ,
regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia, International Journal of Cancer, vol.64, issue.10, pp.2375-2382, 2009. ,
DOI : 10.1002/ijc.24664
FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma, Leukemia, vol.11, issue.12, pp.2247-2253, 2005. ,
DOI : 10.1038/nm1093
Abnormally High Levels of Virus-Infected IFN-??+CCR4+CD4+CD25+ T Cells in a Retrovirus-Associated Neuroinflammatory Disorder, PLoS ONE, vol.79, issue.10, p.6517, 2009. ,
DOI : 10.1371/journal.pone.0006517.s002
Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I???associated neuroimmunological disease, Journal of Clinical Investigation, vol.115, issue.5, pp.1361-1368, 2005. ,
DOI : 10.1172/JCI23913DS1
J a c o b s o nS :Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection, pp.1557-1566 ,
The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis, BMC Immunology, vol.9, issue.1, p.41, 2008. ,
DOI : 10.1186/1471-2172-9-41
Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy, Journal of Neuroimmunology, vol.200, issue.1-2, pp.115-124, 2008. ,
DOI : 10.1016/j.jneuroim.2008.06.005
Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells, European Journal of Immunology, vol.107, issue.9, pp.2450-2459, 2010. ,
DOI : 10.1002/eji.201040461
Interleukin-10 Gene Expression and Adult T-Cell Leukemia, Leukemia & Lymphoma, vol.81, issue.3-4, pp.1035-1045, 1996. ,
DOI : 10.1073/pnas.92.4.1057
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma, Leukemia & Lymphoma, vol.19, issue.11, pp.2091-2098, 2008. ,
DOI : 10.1093/annonc/mdm132
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, Journal of Experimental Medicine, vol.170, issue.6, pp.2081-2095, 1989. ,
DOI : 10.1084/jem.170.6.2081
Human interleukin-10 can directly inhibit T-cell growth, Blood, vol.81, pp.2964-2971, 1993. ,
IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines, FEBS Letters, vol.12, issue.27, pp.5207-5212, 2007. ,
DOI : 10.1016/j.febslet.2007.10.008
Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma, Blood, vol.104, issue.10, pp.3305-3311, 2004. ,
DOI : 10.1182/blood-2004-01-0266
Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis, Oncogene, vol.13, pp.135-142, 1996. ,
Regulatory T-cell function of adult T-cell leukemia/lymphoma cells, International Journal of Cancer, vol.20, issue.9, pp.2052-2057, 2007. ,
DOI : 10.1002/ijc.22536
Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells, European Journal of Immunology, vol.94, issue.9 ,
DOI : 10.1002/1521-4141(200109)31:9<2623::AID-IMMU2623>3.0.CO;2-4
The contribution of NF-kappaB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors, Blood, vol.98, issue.4, pp.1200-1208, 2001. ,
DOI : 10.1182/blood.V98.4.1200
Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?, Viruses, vol.3, issue.12, pp.750-769, 2011. ,
DOI : 10.3390/v3060750
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence, Blood, vol.108, issue.3, pp.1021-1029, 2006. ,
DOI : 10.1182/blood-2006-01-0067
URL : https://hal.archives-ouvertes.fr/hal-00022487
The combination of arsenic, interferon-alpha, and zidovudine restores an ???immunocompetent-like??? cytokine expression profile in patients with adult T-cell leukemia lymphoma, Retrovirology, vol.10, issue.1, p.91, 2013. ,
DOI : 10.1182/blood-2006-01-0067
URL : https://hal.archives-ouvertes.fr/inserm-00868737